Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Hie‐Won Hann"'
Publikováno v:
Livers, Vol 4, Iss 1, Pp 31-35 (2023)
Chronic hepatitis B is still a disease process that affects millions around the world. Serologies used to diagnose and follow the progression (or resolution) of the disease can be confusing for clinicians. Further, throughout years of treatment, ther
Externí odkaz:
https://doaj.org/article/3266a12d787244bbba73b0e55d9f01bf
Autor:
Selena Y. Lin, Wei Xia, Amy K. Kim, Dion Chen, Shelby Schleyer, Lin Choi, Zhili Wang, James P. Hamilton, Harry Luu, Hie-Won Hann, Ting-Tsung Chang, Chi-Tan Hu, Abashai Woodard, Terence P. Gade, Ying-Hsiu Su
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract An optimized hepatocellular carcinoma (HCC)-targeted methylation next generation sequencing assay was developed to discover HCC-associated methylation markers directly from urine for HCC screening. Urine cell-free DNA (ucfDNA) isolated from
Externí odkaz:
https://doaj.org/article/97ab82d66331480894a625b29cff3494
Autor:
Man-Fung Yuen, Scott Fung, Xiaoli Ma, Tuan T. Nguyen, Tarek Hassanein, Hie-Won Hann, Magdy Elkhashab, Ronald G. Nahass, James S. Park, Ira M. Jacobson, Walid S. Ayoub, Steven-Huy Han, Edward J. Gane, Katie Zomorodi, Ran Yan, Julie Ma, Steven J. Knox, Luisa M. Stamm, Maurizio Bonacini, Frank Weilert, Alnoor Ramji, Michael Bennett, Natarajan Ravendhran, Sing Chan, Douglas T. Dieterich, Paul Yien Kwo, Eugene R. Schiff, Ho S. Bae, Jacob Lalezari, Kosh Agarwal, Mark S. Sulkowski
Publikováno v:
JHEP Reports, Vol 6, Iss 4, Pp 100999- (2024)
Background & Aims: The investigational first-generation core inhibitor vebicorvir (VBR) demonstrated safety and antiviral activity over 24 weeks in two phase IIa studies in patients with chronic HBV infection. In this long-term extension study, patie
Externí odkaz:
https://doaj.org/article/79c1f480374a43d2b19433829b3f31b0
Publikováno v:
Livers, Vol 3, Iss 3, Pp 325-330 (2023)
Chronic hepatitis B is still prevalent globally. Many patients are treated for many years with nucleos(t)ide analogues to prevent the virus from actively replicating. However, although it typically requires consecutive treatment for more than 10 year
Externí odkaz:
https://doaj.org/article/6c14c050ebc9438c895b0634a83a21d0
Publikováno v:
Livers, Vol 3, Iss 2, Pp 232-239 (2023)
Chronic hepatitis B remains a major public health concern and a leading cause of morbidity and mortality worldwide, specifically through its causative role in chronic liver disease and hepatocellular carcinoma. Worldwide, it affects up to 292 million
Externí odkaz:
https://doaj.org/article/c77e1cebdabc47f6b77c514b7045dd28
Autor:
Calvin Q. Pan, Nezam H. Afdhal, Victor Ankoma‐Sey, Ho Bae, Michael P. Curry, Douglas Dieterich, Lynn Frazier, Andrew Frick, Hie‐Won Hann, W. Ray Kim, Paul Kwo, Scott Milligan, Myron J. Tong, K. Rajender Reddy
Publikováno v:
Hepatology Communications, Vol 6, Iss 8, Pp 1881-1894 (2022)
Abstract Real‐world data are limited on tenofovir alafenamide (TAF). We aimed to study TAF real‐world outcomes with other first‐line regimens for chronic hepatitis B (CHB). We enrolled patients with CHB from 10 centers retrospectively and follo
Externí odkaz:
https://doaj.org/article/c069a6f091ce4455a5cb4d4d17687cc2
Autor:
Selena Y. Lin, Yih‐Ping Su, Evan R. Trauger, Benjamin P. Song, Emilie G.C. Thompson, Malcolm C. Hoffman, Ting‐Tsung Chang, Yih‐Jyh Lin, Yu‐Lan Kao, Yixiao Cui, Hie‐Won Hann, Grace Park, Fwu‐Shan Shieh, Wei Song, Ying‐Hsiu Su
Publikováno v:
Hepatology Communications, Vol 5, Iss 10, Pp 1649-1659 (2021)
Integrated hepatitis B virus (HBV) DNA, found in more than 85% of HBV‐associated hepatocellular carcinomas (HBV‐HCCs), can play a significant role in HBV‐related liver disease progression. HBV‐host junction sequences (HBV‐JSs), created thro
Externí odkaz:
https://doaj.org/article/ecd60a7c58844130a5ab17d24d328f52
Autor:
Selena Y. Lin, Dina Halegoua-DeMarzio, Peter Block, Yu-Lan Kao, Jesse Civan, Fwu-Shan Shieh, Wei Song, Hie-Won Hann, Ying-Hsiu Su
Publikováno v:
Diagnostics, Vol 13, Iss 9, p 1537 (2023)
Hepatitis B virus (HBV)-host junction sequences (HBV-JSs) has been detected in the urine of patients with HBV infection. This study evaluated HBV-JSs as a marker of minimum residual disease (MRD) and tumor recurrence after treatment in HBV-hepatocell
Externí odkaz:
https://doaj.org/article/4924b7012bf34cc3aebb5a61c75f0761
Publikováno v:
Case Reports in Gastroenterology, Vol 17, Iss 1, Pp 104-104 (2023)
Hepatitis B virus infections are prevalent worldwide, but the outcomes of infection vary greatly from host to host. In many endemic regions, vertical transmission from mother to child is most common. In this transmission setting, virus genotype and s
Externí odkaz:
https://doaj.org/article/e91a98b50dc04bd1ba92b8eb495f1096
Publikováno v:
Hepatic Oncology, Vol 8, Iss 1 (2021)
Chronic hepatitis B virus (HBV) infection is a major public health challenge on the global scale. Affecting hundreds of millions worldwide, HBV is a leading risk factor for hepatocellular carcinoma (HCC). Clinical outcomes from chronic HBV infection
Externí odkaz:
https://doaj.org/article/6e2b58926a344133a513620b96fb11ac